GlassScriptPhysician profile
Jeffrey Osborne
NPI 1730527631
$18,161.34
in general payments reported to CMS, 2019-2025
12 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $124 · 2021: $300 · 2022: $393 · 2023: $125 · 2024: $966 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,447.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $5,234.00 | 2019 | |
| Smith+Nephew, INC. | $4,780.91 | 2019-2025 | Q-Fix |
| Arthrex, INC. | $3,486.49 | 2019 | |
| Stryker Corporation | $2,733.34 | 2019-2025 | Salvation, Mako, Alphavent |
| Medical Device Business Services, INC. | $643.03 | 2019 | |
| Catalyst Orthoscience | $412.53 | 2022-2024 | Catalyst Csr Shoulder System |
| Zimmer Biomet Holdings, INC. | $337.35 | 2024-2025 | Comprehensive Shoulder System, Identity, Tapestry |
| Encore Medical, LP | $290.28 | 2024 | Djo Surgical |
| Anika Therapeutics, INC. | $143.29 | 2024 | Ovo Motion, Integrity, X-Twist |
| Zak Ortho | $55.71 | 2025 | |
| Baxter Healthcare | $24.56 | 2021 | |
| Ethicon US, LLC | $19.85 | 2025 | Stratafix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Osborne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.